Frances M. Zipp is the Group Executive Vice President and Global Head of Quality
Before joining Teva in 2008, Ms. Zipp was the Senior Vice President of Quality at Barr Pharmaceuticals, and prior to that was Senior Vice President of Quality for Wyeth Pharmaceuticals. Ms. Zipp has held various roles related to drug development, quality, and operations and regulatory affairs at Wyeth and Novartis (Ciba).
Ms. Zipp holds a B.Sc. in Chemistry from Duke University.